Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)
1 clinical trials · Condition
◉ Watch Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)
| Record | Firm | Date |
|---|---|---|
| IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting (NCT02967289) | UNICANCER | 2017-03-27 |
Track Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2) automatically
Every clearance here is in the API, with alerts when new ones post.